Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Malignant melanoma with BRAFV600 mutation

More melanomas in advanced stages – pandemic-related late effects?

    • Dermatology and venereology
    • Education
    • Market & Medicine
    • Oncology
    • Prevention and health care
    • RX
    • Studies
  • 3 minute read

Uptake of skin cancer screening plummeted in the corona pandemic. Therefore, early detection and treatment of skin cancer now deserves special attention. In patients with advanced melanoma and a BRAFV600 mutation, the combination of encorafenib plus binimetinib has proven effective.

Two years after the outbreak of the Corona pandemic, its impact on malignant melanoma care is becoming apparent. Uptake of skin cancer screening exams in 2020 was massively lower than the previous year, and this trend continued in the first half of 2021 with an average decrease of 14.3% compared to 2019, data from Germany show [1,2]. A look at several European countries indicates a slump in the number of skin cancer diagnoses, although data on this are not yet available for Germany, Austria and Switzerland [3]. Experts fear that there may be an increase in tumors detected only at advanced stages in subsequent years [4]. Preliminary data from Greece and France show that fewer melanomas were diagnosed overall in both countries than would have been expected [5,6]. In addition, more melanomas were diagnosed in advanced stages. In Greece, significantly more cases were detected in stages IIC, III, and IV in 2020 than in previous years [5]. After the first lockdown in 2020 in France, the proportion of stage III melanomas diagnosed doubled compared with 2019 (13% vs. 6%), whereas the proportion of stage IV melanomas remained constant (1% vs. 2%) [6]. The consequences of these delayed diagnoses for the health care system and the impact on the need for treatment of future cases remain to be seen.

 

 

Targeted therapy with encorafenib plus binimetinib

Experts agree that it is more important than ever to waste no time in the early detection and treatment of skin cancer [3]. In patients with advanced melanoma and a BRAFV600 mutation, the combination of encorafenib (Braftovi®) plus binimetinib (Mektovi®), among others, has proven effective [7,10–12]. Especially in advanced malignant melanoma, it is important to act quickly, especially since brain metastases, among other things, can be a frequent complication [13]. In this setting, targeted therapy can improve outcome [14–16]. Intracranial efficacy in patients with advanced BRAF-mutated malignant melanoma was observed with the combination of encorafenib plus binimetinib [10,11, 16,17]. In addition, initial evidence from day-to-day care of patients with advanced BRAFV600-mutated malignant melanoma using encorafenib (Braftovi®) plus binimetinib (Mektovi®) indicates adequate safety [10–12]. The tolerability profile observed to date is broadly consistent with the results of the COLUMBUS trial (box) ( median follow-up: 8.1 months)  [7,12,18,19].

Source: Pierre Fabre
 

Literature:

  1. “Fewer skin cancer screenings in corona pandemic: delayed skin cancer diagnoses worsen prognosis,” BVDD, Feb. 17, 2022.
  2. Mangiapane S, et al: Central Institute for Health Care in the Federal Republic of Germany. www.zi.de/publikationen/trendreport-covid-krise, (last accessed May 30, 2022).
  3. Cariti C, et al: Cancers (Basel) 2021; 13(23): 6071.
  4. “Skin Cancer Month 2022: Possible late effects of pandemic feared in malignant melanoma,” Pierre Fabre, April 04, 2022.
  5. Lallas A, et al: J Am Acad Dermatol2021; 85(3): 721-723.
  6. Molinier R, et al: J Eur Acad Dermatol & Venereol 2021: 10.1111/jdv.17802.
  7. Dummer R, et al: Journal of Clinical Oncology 2021; 39(15_suppl): 9507-9507.
  8. Dummer R, et al: The Lancet Oncology 2018; 19(10): 1315-1327.
  9. Dummer R, et al: The Lancet Oncology 2018; 19(5): 603-615.
  10. Technical Information BRAFTOVI®, www.swissmedicinfo.ch, (last accessed May 30, 2022).
  11. Technical Information MEKTOVI®, www.swissmedicinfo.ch, (last accessed 30.05.2022)
  12. Richtig E, et al: Journal of Clinical Oncology 2021; 39(15_suppl): 9555.
  13. Gutzmer R, et al: Cancer Treat Rev 2020; 89: 102083.
  14. Saberian C, et al: Neurooncol Adv 2021; 3(Suppl 5): v75-v85.
  15. Drago JZ, et al. : Melanoma Res 2019; 29(1): 65-69.
  16. Holbrook K, et al: Cancer 2020; 126(3): 523-530.
  17. Khullar K, et al: Melanoma Res 2021; 31(4): 393-396.
  18. Ascierto PA, et al: Eur J Cancer 2020; 126: 33-44.
  19. Gogas H, et al: Eur J Cancer 2021; 152: 116-128.

 

DERMATOLOGY PRACTICE 2022; 32(3): 44

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
Related Topics
  • Melanoma
  • mutation
  • Skin cancer
Previous Article
  • Risk of anaphylaxis

Guideline recommendations up-to-date

  • Allergology and clinical immunology
  • Education
  • General Internal Medicine
  • RX
  • Studies
View Post
Next Article
  • Modern diabetes therapy

With an eye on the heart and kidney

  • Cardiology
  • Education
  • Endocrinology and Diabetology
  • General Internal Medicine
  • Nephrology
  • Partner Content
  • RX
View Post
You May Also Like
View Post
  • 14 min
  • IBDmatters - Advanced Therapeutic Treatments

Examinations and considerations before therapy

    • CME continuing education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Infectiology
    • RX
    • Studies
    • Training with partner
View Post
  • 12 min
  • Liver steatosis with metabolic dysfunction

New nomenclature for non-alcoholic fatty liver disease

    • CME continuing education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • RX
    • Studies
View Post
  • 5 min
  • Obesity in childhood and adolescence

Multifactorial disease with multiple implications

    • Congress Reports
    • General Internal Medicine
    • Nutrition
    • Pediatrics
    • Prevention and health care
    • RX
View Post
  • 9 min
  • Venous thromboembolism prevention

PCSK9 inhibitors: Current evidence, mechanisms and unanswered questions

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 4 min
  • Prostate cancer

NeuroSAFE: New surgical technique preserves erectile function

    • Congress Reports
    • Oncology
    • RX
    • Studies
    • Surgery
    • Urology
View Post
  • 7 min
  • Study report

Scabies treatment: benzyl benzoate in direct comparison with permethrin

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • General Internal Medicine
    • Infectiology
    • RX
    • Studies
    • Tropical and travel medicine
View Post
  • 14 min
  • Innovative approaches in glioblastoma treatment

Synergistic combination therapies and the potential of phytotherapy and mycotherapy

    • RX
    • Education
    • Neurology
    • Oncology
    • Pharmaceutical medicine
    • Phytotherapy
    • Studies
View Post
  • 5 min
  • Acute heart failure

Diuretic therapy for decongestion – what are the “unmet needs”?

    • Cardiology
    • Education
    • General Internal Medicine
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    New nomenclature for non-alcoholic fatty liver disease
  • 2
    Examinations and considerations before therapy
  • 3
    Interplay between cancer and mental illness
  • 4
    Constant dripping – alcohol and cancer
  • 5
    Medical and psychosocial perspectives

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.